Clinical responses to intralymphatic whole-cell melanoma vaccine augmented by in vitro incubation with alpha-interferon.
Wiseman
C
C
Los Angeles Oncologic Institute, St. Vincent Medical Center, California 90057.
Presant
C
C
Rao
R
R
Smith
J
J
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D007370:Interferon Type I / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D008545:Melanoma / Q000532:radiotherapy / Q000628:therapy*; D008875:Middle Aged; D011994:Recombinant Proteins
D007370:Interferon Type I; D011994:Recombinant Proteins